Curt Styres and Mike Accursi take home two of IL Indoors end of the year awards.
We sat down with defenceman, James Barclay, to ask him the hard-hitting questions in this edition of Q and Eh? presented by Admiral Insurance.
Paul Tutka | April 24, 2020 While the 2020 National Lacrosse League regular season was recently retired due to the entire world being put on pause, the pandemic can't prevent us from shining a spotlight on the spectacular…
We sat down with rookie defenceman, Nonkon Thompson, to ask him the hard-hitting questions in our fifth edition of Q and Eh? presented by Admiral Insurance
The National Lacrosse League announced that the league has cancelled the remainder of the regular season due to the ongoing situation with COVID-19 and ensuring the safety of our fans, players and staff
We sat down with rookie defenceman, Trevor Smyth, to ask him the hard-hitting questions in our fourth edition of Q and Eh? presented by Admiral Insurance.
We sat down with Thunderbirds Forward, Mike Burke, to ask him the hard-hitting questions in our third edition of Q and Eh? presented by Admiral Insurance.
We sat down with longtime NLL veteran defenceman, Scott 'Soupy' Campbell, to ask him the hard-hitting questions in our second edition of Q and Eh? presented by Admiral Insurance
The NLL announced the launch of two new online content offerings designed to give fans additional engagement points during the current interruption of play and going forward into the future as well.
Thunderbirds To Focus On Community Building & Grassroots Development Alongside Chet Koneczny and LaxLife.ca
Best teammate to follow on social media? Kyle Jackson What is your favourite food? Ribeye steak Who is your celebrity crush? Emma Watson One lacrosse player you looked up to as a kid? John Grant Jr. What is your go to meal? Salmon, rice, veggy…
"The National Lacrosse League has determined that it is in the best interests of our fans, our players, our coaches and our staff to temporarily suspend play until further notice due to concerns over COVID-19. We will continue to evaluate…